Researchers at Karolinska Institutet in Sweden, in collaboration with the University of Innsbruck in Austria, have developed a simpler and more effective screening method for cervical cancer than… read more.
Bare minimum reimbursement rates could be a factor in why some clinics may be struggling to offer HPV vaccination in the U.S. MUSC Hollings Cancer Center researcher Kalyani… read more.
At-home high-risk human papillomavirus (hrHPV) sampling kits can help increase cervical cancer screening among under-screened women from low-income backgrounds, according to findings from a US-based clinical trial published… read more.
In a joint initiative that includes Hollings Cancer Center and the Department of Pediatrics, MUSC researchers launched a community mobile health van in 2021 to help to increase… read more.
Although young cancer survivors face an elevated risk for later developing cervical, oropharyngeal, and several other human papillomavirus (HPV)–related cancers, HPV vaccination rates among this group remain low…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
